Cutler Group LP Adaptive Biotechnologies Corp Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 04, 2022	SELL	$6.4 - $14.73 $13,440 - $30,933	-2,100 Reduced 58.33%	1,500 $3,000
Q1 2022 Apr 14, 2022	BUY	$10.12 - $28.9 $28,335 - $80,920	2,800 Added 350.0%	3,600 $1,000
Q2 2020 Jul 22, 2020	SELL	$24.95 - $48.38 $14,970 - $29,028	-600 Reduced 42.86%	800 $0
Q1 2020 May 07, 2020	BUY	$16.96 - $34.16 $20,352 - $40,991	1,200 Added 600.0%	1,400 $4,000
Q4 2019 Feb 06, 2020	SELL	$24.56 - $32.8 $34,384 - $45,919	-1,400 Reduced 87.5%	200 $2,000
Q3 2019 Oct 28, 2019	BUY	$30.31 - $53.51 $48,496 - $85,616	1,600 New	1,600 $8,000

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.